These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22963438)

  • 1. P2X1 and P2X2 receptors in the central nervous system as possible drug targets.
    Hausmann R; Schmalzing G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
    El-Ajouz S; Ray D; Allsopp RC; Evans RJ
    Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
    Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking.
    Wolf C; Rosefort C; Fallah G; Kassack MU; Hamacher A; Bodnar M; Wang H; Illes P; Kless A; Bahrenberg G; Schmalzing G; Hausmann R
    Mol Pharmacol; 2011 Apr; 79(4):649-61. PubMed ID: 21191044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of P2X1, P2X2, P2X3, and P2X4 receptor subunits in rat nodose ganglion neurons.
    Wang L; Feng D; Yan H; Wang Z; Pei L
    PLoS One; 2014; 9(5):e96699. PubMed ID: 24798490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X receptor chimeras highlight roles of the amino terminus to partial agonist efficacy, the carboxyl terminus to recovery from desensitization, and independent regulation of channel transitions.
    Allsopp RC; Farmer LK; Fryatt AG; Evans RJ
    J Biol Chem; 2013 Jul; 288(29):21412-21421. PubMed ID: 23740251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
    Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
    Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis.
    Custer EE; Knott TK; Cuadra AE; Ortiz-Miranda S; Lemos JR
    J Neuroendocrinol; 2012 Apr; 24(4):674-80. PubMed ID: 22340257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
    Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
    J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels.
    Allsopp RC; Evans RJ
    J Biol Chem; 2011 Dec; 286(52):44691-701. PubMed ID: 22027824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt bridge switching from Arg290/Glu167 to Arg290/ATP promotes the closed-to-open transition of the P2X2 receptor.
    Hausmann R; Günther J; Kless A; Kuhlmann D; Kassack MU; Bahrenberg G; Markwardt F; Schmalzing G
    Mol Pharmacol; 2013 Jan; 83(1):73-84. PubMed ID: 23041661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.
    Tian M; Abdelrahman A; Baqi Y; Fuentes E; Azazna D; Spanier C; Densborn S; Hinz S; Schmid R; Müller CE
    J Med Chem; 2020 Jun; 63(11):6164-6178. PubMed ID: 32345019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors.
    Allsopp RC; Lalo U; Evans RJ
    J Biol Chem; 2010 Oct; 285(43):32770-32777. PubMed ID: 20699225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of P2X receptors expressed in rat pulmonary arteries.
    Syed NI; Tengah A; Paul A; Kennedy C
    Eur J Pharmacol; 2010 Dec; 649(1-3):342-8. PubMed ID: 20868665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic P2X receptors: structural models and analysis of ligand-target interaction.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R
    Eur J Med Chem; 2015 Jan; 89():561-80. PubMed ID: 25462266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics to identify proteins interacting with P2X2 ligand-gated cation channels.
    Singh H; Warburton S; Vondriska TM; Khakh BS
    J Vis Exp; 2009 May; (27):. PubMed ID: 19455095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
    Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
    Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescent approach for identifying P2X1 ligands.
    Ruepp MD; Brozik JA; de Esch IJ; Farndale RW; Murrell-Lagnado RD; Thompson AJ
    Neuropharmacology; 2015 Nov; 98():13-21. PubMed ID: 26026951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats.
    Teixeira JM; Oliveira MC; Nociti FH; Clemente-Napimoga JT; Pelegrini-da-Silva A; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Oct; 645(1-3):79-85. PubMed ID: 20558155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.